Fast Facts ICER’s 1/31/2020 Final Release of the 2020 Value Assessment Framework Fast Facts: ICER’s 2020 Value Assessment Framework ICER’s 1/9/2020 Final Evidence Report on JAK Inhibitors for Rheumatoid Arthritis Fast Facts: JAK Inhibitors for Rheumatoid Arthritis ICER’s 12/9/2019 Final Evidence Report on Oral Semaglutide for Type 2 Diabetes Mellitus Fast Facts: Oral Semaglutide for Type 2 Diabetes Mellitus